NUTRA PHARMA CORP

Nutra Pharma Corp. is a biopharmaceutical company focused on developing drugs for autoimmune disorders, viral diseases, and pain. The company was incorporated in California on February 1, 2000, initially as Exotic-Bird.com, and has been conducting operations since October 2003. Nutra Pharma engages in drug discovery research and development, as well as the acquisition, licensing, and commercialization of pharmaceutical products and technologies. This includes homeopathic drugs, which are natural products with ingredients listed in the Homeopathic Pharmacopoeia of the United States (HPUS), and ethical drugs, which are licensed drugs that have received Federal Drug Administration (FDA) approval after extensive testing. Nutra Pharma has launched several consumer products. In October 2009, it introduced Cobroxin, an over-the-counter pain reliever for moderate to severe chronic pain. This was followed by Nyloxin in May 2010, a stronger over-the-counter pain reliever for severe chronic pain. The company expanded into the animal health market with Pet Pain-Away in December 2014, an over-the-counter pain reliever for cats and dogs, and Equine Pain-Away in October 2019, an over-the-counter topical pain reliever for horses. In March 2021, Nutra Pharma launched Luxury Feet, an over-the-counter pain reliever and anti-inflammatory product for women experiencing pain or discomfort from high heels. As of October 2021, the company also manufactures private-labeled products for third-party distributors. Nutra Pharma seeks strategic licensing partnerships to manage risks in drug development.